Details
Manufacturer
Xepa-Soul Pattinson (Malaysia) Sdn. Bhd.
Registraction Number
MAL15085019AZ
Content
- Active Ingredient: Each tablet contains montelukast sodium, a leukotriene receptor antagonist that blocks leukotrienes, substances that can cause narrowing and swelling of airways in the lungs.
Indications:
Xepa Altra 4mg Chewable Tablet is used for:
-
- Chronic treatment and prophylaxis of asthma in children aged 2 to 5 years.
- Prevention of exercise-induced bronchoconstriction in children aged 2 years and older.
- Relief of symptoms of seasonal allergic rhinitis in children aged 2 years and older.
- As an alternative treatment to low-dose inhaled corticosteroids for children aged 2 to 5 years with mild persistent asthma who cannot use inhaled corticosteroids.
Instructions:
-
- For children aged 2 to 5 years, administer one 4mg chewable tablet daily in the evening.
- Tablets should be chewed before swallowing.
- If taken with food, montelukast should be taken at least 1 hour before or 2 hours after food.
- Do not use montelukast to treat acute asthma attacks; always have a short-acting inhaled beta-agonist available for such situations.
- Regular follow-up with the doctor is recommended to assess asthma control.
View more about Xepa Altra 4mg Tab on main site